Cite
HARVARD Citation
Atri, A. et al. (n.d.). [DT‐02–02]: IDALOPIRDINE, A 5‐HT6 ANTAGONIST, AS ADJUNCTIVE THERAPY TO ACETYLCHOLINESTERASE INHIBITORS IN PATIENTS WITH MILD‐MODERATE ALZHEIMER's DISEASE: KEY OUTCOMES FROM THE STAR PHASE III PROGRAM. Alzheimer's & dementia. pp. P1476-P1477. [Online].